Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
13.18
0.00 (0.00%)
May 14, 2025, 9:30 AM - Market open
Benitec Biopharma Employees
Benitec Biopharma had 16 employees as of June 30, 2024. The number of employees decreased by 2 or -11.11% compared to the previous year.
Employees
16
Change (1Y)
-2
Growth (1Y)
-11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,338,438
Market Cap
336.02M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BNTC News
- 4 weeks ago - Benitec Biopharma: An Under-The-Radar And Undervalued Gene Therapy Developer - Seeking Alpha
- 7 weeks ago - Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering - GlobeNewsWire
- 3 months ago - Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update - GlobeNewsWire
- 6 months ago - Benitec Biopharma to Participate in Upcoming Investor Conferences in December - GlobeNewsWire
- 6 months ago - Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update - GlobeNewsWire
- 6 months ago - Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference - GlobeNewsWire
- 7 months ago - Benitec Biopharma: OPMD Program Continues To Advance With Catalysts - Seeking Alpha
- 7 months ago - Benitec Biopharma Announces Updated Investor Webcast Information - GlobeNewsWire